Beijing Honghui Biopharmaceutical Co., Ltd.

To evaluate the efficacy and safety of efonidipine hydrochloride tablets produced by Beijing Jialin Pharmaceutical Co., Ltd. in the treatment of subjects with primary mild to moderate hypertension.

After a single oral administration of different doses of efonidipine hydrochloride tablets to healthy subjects, the concentration of efonidipine in plasma was determined to study the pharmacokinetic characteristics of efonidipine hydrochloride tablets in humans after a single oral administration.

After multiple oral single-dose administration of efonidipine hydrochloride tablets to healthy subjects, the concentration of efonidipine in plasma was measured to study the pharmacokinetic characteristics of efonidipine hydrochloride tablets in humans after multiple oral administration